GILT files Form 144 for proposed ordinary share sales

GILT filed a Form 144 reporting proposed sales of ordinary shares.

Rhea-AI Filing Summary

GILT filed a Form 144 reporting proposed sales of ordinary shares. The notice lists two tranches of shares linked to the Employee Stock Options Plan: 7,840 shares (issued 09/19/2022) and 5,488 shares (issued 02/28/2024). Both tranches are described as cash upon exercise. The filing names Oppenheimer & Co. Inc. as a broker and indicates the shares trade on Nasdaq. Timing and aggregate proceeds are not detailed in the provided excerpt.

Insights

Corporate Secretary

Form 144 notifies proposed affiliate sales tied to option exercises.

The filing lists two option-derived tranches: 7,840 and 5,488 ordinary shares, each described as exercisable for cash. The entries identify the Employee Stock Options Plan as the award source and Oppenheimer & Co. Inc. as a listed broker.

These notices are routine regulatory disclosures of planned sales by affiliates; actual sale execution, timing, and proceeds depend on subsequent transactions and are not specified in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does GILT's Form 144 report?

It reports proposed sales of ordinary shares by an affiliate. The filing lists 7,840 and 5,488 shares tied to employee option grants and states sales are cash upon exercise under the Employee Stock Options Plan.

Are the exact sale proceeds disclosed in GILT's Form 144?

No, the excerpt does not disclose aggregate proceeds. It lists share counts and issuance dates but does not provide sale prices, total cash expected, or dollar proceeds from the proposed transactions.

Who is listed as the broker for the proposed sales?

The filing names Oppenheimer & Co. Inc. at 85 Broad St., New York. The excerpt shows the broker reference but does not describe the planned distribution method or execution timeline.

What types of awards are the shares associated with on the Form 144?

The shares come from the Employee Stock Options Plan. Two award dates are shown: 09/19/2022 and 02/28/2024, indicating option-originated shares exercisable for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 08:35 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001978291
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILAT SATELLITE NETWORKS LTD
SEC File Number	000-21218
Address of Issuer	C/O GILAT SATELLITE NETWORKS INC 1651 OLD MEADOW RD MCLEAN VIRGINIA 22102
Phone	7037349401
Name of Person for Whose Account the Securities are To Be Sold	Kerbel Doron
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	13328	218445.92	73831318	03/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares	09/19/2022	Employee Stock Options Plan	Issuer			7840	03/17/2026	Cash Upon Exercise
Ordinary shares	02/28/2024	Employee Stock Options plan	Issuer			5488	03/17/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 12/17/2025
Date of Notice	03/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Doron Kerbel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)